IVERMECTIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ivermectin, and what generic alternatives are available?
Ivermectin is a drug marketed by Padagis Israel, Teva Pharms Usa, Zydus Lifesciences, Taro, and Edenbridge Pharms. and is included in six NDAs.
The generic ingredient in IVERMECTIN is ivermectin. There are five drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ivermectin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ivermectin
A generic version of IVERMECTIN was approved as ivermectin by EDENBRIDGE PHARMS on October 24th, 2014.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for IVERMECTIN?
- What are the global sales for IVERMECTIN?
- What is Average Wholesale Price for IVERMECTIN?
Summary for IVERMECTIN
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 15 |
| Raw Ingredient (Bulk) Api Vendors: | 77 |
| Clinical Trials: | 206 |
| Patent Applications: | 3,070 |
| Drug Prices: | Drug price information for IVERMECTIN |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for IVERMECTIN |
| What excipients (inactive ingredients) are in IVERMECTIN? | IVERMECTIN excipients list |
| DailyMed Link: | IVERMECTIN at DailyMed |
Recent Clinical Trials for IVERMECTIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Public Health Laboratory Ivo de Carneri | Phase 2 |
| National Public Health Institute of Liberia | Phase 2 |
| Vector Borne & Neglected Tropical Disease Control Division, Ministry of Health, Uganda | Phase 3 |
Pharmacology for IVERMECTIN
| Drug Class | Antiparasitic Pediculicide |
Medical Subject Heading (MeSH) Categories for IVERMECTIN
Anatomical Therapeutic Chemical (ATC) Classes for IVERMECTIN
Paragraph IV (Patent) Challenges for IVERMECTIN
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| SKLICE | Lotion | ivermectin | 0.50% | 202736 | 1 | 2017-09-01 |
| SOOLANTRA | Cream | ivermectin | 1% | 206255 | 1 | 2016-12-30 |
US Patents and Regulatory Information for IVERMECTIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Israel | IVERMECTIN | ivermectin | CREAM;TOPICAL | 210225-001 | Apr 13, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Taro | IVERMECTIN | ivermectin | LOTION;TOPICAL | 210720-001 | May 6, 2020 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Pharms Usa | IVERMECTIN | ivermectin | CREAM;TOPICAL | 210019-001 | Sep 13, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Zydus Lifesciences | IVERMECTIN | ivermectin | CREAM;TOPICAL | 215210-001 | Aug 2, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Edenbridge Pharms | IVERMECTIN | ivermectin | TABLET;ORAL | 204154-001 | Oct 24, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
